Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review

Preclinical and early clinical evidence suggest that radical radiotherapy of oligometastatic disease in non-small cell lung cancer (NSCLC) patients can impact outcomes with relatively limited toxicity. Whilst data from phase 2 randomized trials suggesting an improved overall survival (OS) with this...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundahl, Nora, Lievens, Yolande
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Oligometastatic NSCLC: Definition and Treatment Opportunities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350107/
https://www.ncbi.nlm.nih.gov/pubmed/34430377
http://dx.doi.org/10.21037/tlcr-20-1051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350107/
https://www.ncbi.nlm.nih.gov/pubmed/34430377
http://dx.doi.org/10.21037/tlcr-20-1051

Ejemplares similares